SEC Form 4 · accession 0001209191-17-026315
CUMBERLAND PHARMACEUTICALS INC · CPIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas R Lawrence
Director
Period of report
Apr 7, 2017
Accepted (ET)
Apr 7, 2017 · 5:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001087294
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 7, 2017 | S | 6,000 | $6.40 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares transferred to accredited investor